肝细胞癌的分子标志物：作为诊断/预后标志物的新趋势！
Hepatocellular Carcinoma's Molecular Markers: The New Trend as Diagnostic/Prognostic Markers!
作者信息
Badwei Nourhan
机构信息
Tropical Medicine, Gastroenterology and Hepatology, Hepatoma Group, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
出版信息
J Clin Exp Hepatol. 2023 Jul-Aug;13(4):718-719. doi: 10.1016/j.jceh.2023.01.007. Epub 2023 Jan 17.
Hepatocellular carcinoma represents one of the serious and common liver diseases that need to be early diagnosed and promptly treated; Hence various researchers have paid great attention to the utility of molecular markers in the diagnosis and/or prognosis of hepatic neoplasms. Our letter focused on summarizing their role as diagnostic/prognostic tools in patients with hepatocellular tumours for a better outcome.Image 1.
肝细胞癌是需要早期诊断和及时治疗的严重且常见的肝脏疾病之一；因此，众多研究人员高度关注分子标志物在肝脏肿瘤诊断和/或预后方面的应用。我们的信函着重总结了它们作为肝细胞肿瘤患者诊断/预后工具的作用，以期获得更好的结果。图1。
Zotero 插件